Sign in
Taking people in United StatesNo phase

Adaptive Decision Support for Addiction Treatment Master

Key facts

Who runs it
Yale University
Where
Guilford and New Haven, United StatesSee the 3 sites
Trial code
Status
Recruiting
People taking part
1,912 people, planned
Started
21 Mar 2025
Expected to end
31 Mar 2028
Type of study
Interventional, 3 groups
Treatments tested
  • EMBED CDS
  • Nurse prompt to complete COWS
  • Provider Prompt
  • Patient facing materials
  • Optimized EMBED
  • Name of Intervention
Record updated
11 June 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Emergency department patient
  • 18 years of age or older
  • Moderate to severe opioid use disorder

Who cannot take part

  • Currently receiving medication for opioid use disorder
  • Under 18 years of age
  • Pregnant

This trial is currently available in United States.

  • Yale-New Haven Shoreline Medical CenterGuilford, United StatesContact: Edward Melnick, MD, MHSTaking people
  • Yale New Haven HospitalNew Haven, United StatesContact: Edward Melnick, MD, MHSTaking people
  • Yale New Haven Hospital- St. RaphaelNew Haven, United StatesContact: Edward Melnick, MD, MHSTaking people

About the trial

What the trial wants to find out

This study refines and optimizes the EMBED* clinical decision support (CDS; see NCT03658642) to increase number of ED physicians following standard of care for the administration of buprenorphine to appropriate patients with opioid use disorder.

Read full original descriptionShow less

This study does not have open enrollment. Investigators will use a Multiphase Optimization STrategy (MOST) framework study with preparation, optimization, and confirmatory phases.

Optimization Phase: This phase has two stages. In stage 1, investigators will conduct a 2x2x2 factorial trial to expand EMBED is expanded to include sustainable implementation strategies: nurse prompt for withdrawal assessment, and targeted clinician prompts to use the CDS along with individualized patient resources to promote equity and motivate readiness to start treatment. In Stage 2, investigators will improve CDS usability via serial randomized testing to inform iterative refinement of the CDS interface and workflow to minimize user errors, task disruption, and abandonment through identification of specific targets for improvement via application of novel CDS outcome measures in serial randomized tests.

Evaluation phase: Investigators will conduct a randomized trial to compare the efficacy effectiveness of the optimized package compared to the original on ED-initiation of buprenorphine rates in patients with OUD.

*EMBED is a user user-centered, clinician clinician-facing clinical decision support system integrated into the electronic health record workflow to facilitate initiating buprenorphine in the emergency department by: diagnosing opioid use disorder with a checklist based on the diagnostic criteria of the DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, fifth edition), assessing the severity of withdrawal with the Clinical Opioid Withdrawal Scale (COWS), motivating patients to accept treatment with a scripted brief negotiation interview, and automating the electronic health record workflow, including clinical and after visit documentation, order entry, prescribing, and referral for ongoing treatment in the community

The 3 groups in the trial

  • Optimization Phase, Stage1: Factorial TrialTreatment being tested

    Successful completion of Optimization Phase, Stage 1 Successful completion of the 2x2x2 factorial trial in which investigators expand EMBED to include sustainable implementation strategies: nurse prompt for withdrawal assessment, and targeted clinician prompt to use the CDS along with patient resources to promote equity and motivate readiness to start treatment.

    Treatment: EMBED CDS, Nurse prompt to complete COWS, Provider Prompt, and Patient facing materials

  • Optimization Phase, Stage 2: Rapid serialized testingTreatment being tested

    Successful completion of Optimization Phase, Stage 2: Improve CDS usability via serial randomized testing to inform iterative refinement of the CDS interface and workflow to minimize user errors, task disruption, and abandonment through identification of specific targets for improvement via application of novel CDS outcome measures in serial randomized tests.

    Treatment: EMBED CDS and Name of Intervention

  • Evaluation PhaseTreatment being tested

    Successful completion of the Evaluation phase: Investigators will conduct a randomized trial to compare the efficacy of the optimized package compared to the original on ED-initiation of buprenorphine rates in patients with OUD.

    Treatment: EMBED CDS and Optimized EMBED

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Adaptive Decision Support for Addiction Treatment (ADAPT)
Publications
Record updated
11 June 2026